Thereson S.p.A. has developed DIAPASON, a medical device that uses therapeutic magnetic resonance technology to treat diabetic foot ulcers. The device includes a console that generates electrical signals and a set of emitters that convert the signals into pulsating magnetic fields for systemic treatment and treatment of the ulcer area. Thereson's primary goal is to improve patient outcomes and quality of life by offering effective and easy-to-use medical devices. The company values quality and attention to the needs of its users and relies on evidence-based clinical investigation and scientific research to demonstrate the validity of its products.